-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendices.pdf
May 22, 2024 - neoplasm"[title] OR "cervical neoplasm"[title] OR "colon neoplasm"[title] OR
"colorectal neoplasm" … neoplasm"[title] OR "cervical neoplasm"[title] OR "colon neoplasm"[title] OR
"colorectal neoplasm" … Serum expression levels of microRNA-382-3p, -598-3p, -1246
and -184 in breast cancer patients. … A novel panel of microRNAs provides a sensitive and
specific tool for the diagnosis of breast cancer … Potential of blood-based biomarker
approaches in endometrium and breast cancer: a case-control comparison
-
psnet.ahrq.gov/node/45187/psn-pdf
July 11, 2017 - cancer detection: a randomized clinical trial. … Cancer Detection: A Randomized Clinical Trial. … psnet.ahrq.gov/issue/effect-using-same-vs-different-order-second-readings-screening-
mammograms-rates-breast-cancer … psnet.ahrq.gov/issue/effect-using-same-vs-different-order-second-readings-screening-mammograms-rates-breast-cancer … psnet.ahrq.gov/issue/effect-using-same-vs-different-order-second-readings-screening-mammograms-rates-breast-cancer
-
www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-medication-use-risk-reduction-primary-breast-cancer-women
March 23, 2017 - Public Comment on Draft Research Plan: Medication Use for the Risk Reduction of Primary Breast Cancer … Services Task Force posted today a draft research plan on medication use for the risk reduction of primary breast … cancer in women.
-
digital.ahrq.gov/ahrq-funded-projects/clinical-decision-support-disseminating-and-implementing-patient-centered
January 01, 2023 - cancer in a woman with prior breast cancer, the use of CT scan for pulmonary embolism (PE), and education … Frequency and outcomes of BI-RADS category 3 assessments in patients with a personal history of breast … cancer: Full-field digital mammography versus digital breast tomosynthesis. … Frequency and outcomes of BI-RADS category 3 assessments in patients with a personal history of breast … cancer: Full-field digital mammography versus digital breast tomosynthesis.
-
pbrn.ahrq.gov/news/blog/ahrqviews/womens-health-week-2023.html
May 01, 2023 - cancer every other year between the ages 40 and 74. … This recommendation highlights the importance of getting regular breast cancer screening examinations … Regular breast cancer screenings are important for detecting breast cancer years before symptoms develop … In 2022, it was estimated that more than 280,000 women were newly diagnosed with breast cancer, and more … While Black and White women are equally likely to receive a breast cancer diagnosis, Black women are
-
pcmh.ahrq.gov/news/blog/ahrqviews/womens-health-week-2023.html
May 01, 2023 - cancer every other year between the ages 40 and 74. … This recommendation highlights the importance of getting regular breast cancer screening examinations … Regular breast cancer screenings are important for detecting breast cancer years before symptoms develop … In 2022, it was estimated that more than 280,000 women were newly diagnosed with breast cancer, and more … While Black and White women are equally likely to receive a breast cancer diagnosis, Black women are
-
effectivehealthcare-admin.ahrq.gov/products/breast-biopsy/research
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/emery-j-et-al-2007
January 01, 2007 - history of breast/ovarian and colorectal cancer, and provides additional numerical risk information about breast … cancer... … letters was consistent with the regional guidelines in the intervention arm than in the comparison arm (breast … cancer alone and breast and colorectal cancer combined...)."
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/postmenopausal-hormone-prophylaxis-preventive-medication-1996
January 01, 1996 - Breast Cancer
Endogenous estrogen appears to be important in the etiology of breast cancer, but the … Menopausal estrogen replacement therapy and breast cancer. … Menopausal hormone replacement therapy and breast cancer: a meta-analysis. … Noncontraceptive hormone use and risk of breast cancer. … Combined oestrogen-progestogen replacement and breast cancer risk.
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/breastcanfinalrsbulletin.pdf
January 12, 2016 - Preventive Services Task Force Issues Final
Recommendations on Screening for Breast Cancer
Task Force … The Task Force confirmed that screening
mammography is effective in reducing deaths due to
breast cancer … Women in their 40s who have a mother, sister, or daughter with breast cancer may benefit more
than average-risk … While the Task Force noted that screening mammography is effective in reducing deaths from breast
cancer … None of the
studies of breast cancer screening included women in this age group.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/mWobCghbAX938Av48jDqQ4
August 23, 2016 - cancer deaths. … FACT: There are harms
associated with screening for
breast cancer. … The Task Force recognizes that mammography is an important tool in reducing breast
cancer deaths. … cancer mortality and that the
benefits of mammography increase with age. … cancer
screening at this time.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2nGsLfynVxP3XwN-Zgo_sg
August 23, 2016 - cancer deaths. … FACT: There are harms
associated with screening for
breast cancer. … The Task Force recognizes that mammography is an important tool in reducing breast
cancer deaths. … cancer mortality and that the
benefits of mammography increase with age. … cancer
screening at this time.
-
hcup-us.ahrq.gov/reports/statbriefs/sb125.jsp
February 01, 2012 - Between 2000 and 2009, hospitalizations for breast cancer decreased 28 percent and those for cervical … Cancer of breast* in 2000, 121, in 2009, 87. Cancer of bronchus, lung in 2000, 67, in 2009, 71. … of breast
88,000
2.5
$10,300
$4,100
$905
Cancer of kidney and renal pelvis
46,400 … of the breast ($4,100 per day), and cancer of the thyroid ($3,500 per day). … of breast
619,700
18.1%
Cancer of prostate
511,900
14.9%
Secondary malignancies
-
psnet.ahrq.gov/node/46723/psn-pdf
April 12, 2019 - Diagnostic assessment of deep learning algorithms for
detection of lymph node metastases in women with
breast … cancer. … Diagnostic Assessment of Deep Learning Algorithms for Detection
of Lymph Node Metastases in Women With Breast … Cancer. … cancer to pathologists' diagnoses.
-
psnet.ahrq.gov/node/60017/psn-pdf
March 04, 2020 - artificial-intelligence
There is increasing interest in the use of artificial intelligence (AI) to improve breast … cancer detection. … The AI algorithm alone showed better diagnostic
performance in breast cancer detection compared to radiologists … artificial-intelligence-and-diagnostic-errors
https://psnet.ahrq.gov/issue/international-evaluation-ai-system-breast-cancer-screening
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
June 01, 2013 - 3
KQ 5: What are the harms of OC use, including
breast cancer incidence, cervical cancer incidence … Analytic framework for systematic review
BRCA = breast cancer genetic mutation; KQ = Key Question; OC … Harms of OC Use
Breast Cancer
Table E shows the strength of evidence for the effect of OC
use on breast … Ever use of OCs is associated with a
small but significant increase in breast cancer risk, based
on … increase
in risk
BRCA = breast cancer genetic mutation; CI = confidence interval; SOE = strength
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
June 01, 2013 - 3
KQ 5: What are the harms of OC use, including
breast cancer incidence, cervical cancer incidence … Analytic framework for systematic review
BRCA = breast cancer genetic mutation; KQ = Key Question; OC … Harms of OC Use
Breast Cancer
Table E shows the strength of evidence for the effect of OC
use on breast … Ever use of OCs is associated with a
small but significant increase in breast cancer risk, based
on … increase
in risk
BRCA = breast cancer genetic mutation; CI = confidence interval; SOE = strength
-
effectivehealthcare-admin.ahrq.gov/products/cancer-ovarian-contraceptives/research
December 01, 2019 - Breast cancer incidence was slightly but significantly increased in OC users (OR, 1.08; 95% CI, 1.00 … ovarian cancer prevention alone is uncertain, particularly when the potential quality-of-life impact of breast … cancer and vascular events are considered. … Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-evidence-summary.pdf
January 01, 2020 - cancer, luminal breast cancer, or triple-negative
breast cancer. … Results of the Marburg breast
cancer and osteoporosis trial (MABOT). … Assessment of Breast Cancer
Risk Factors Reveals Subtype Heterogeneity. … Past obstetric history and
risk of malignant breast neoplasms. … Breast Cancer.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-evidence-summary.pdf
January 01, 2020 - cancer, luminal breast cancer, or triple-negative
breast cancer. … Results of the Marburg breast
cancer and osteoporosis trial (MABOT). … Assessment of Breast Cancer
Risk Factors Reveals Subtype Heterogeneity. … Past obstetric history and
risk of malignant breast neoplasms. … Breast Cancer.